Related Experiment Video
Updated: Jun 3, 2026

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
Published on: February 17, 2011
Impact of BRCA1 BRCT domain missense substitutions on phosphopeptide recognition
Nicolas Coquelle1, Ruth Green, J N Mark Glover
1Department of Biochemistry, School of Medicine, University of Alberta, Edmonton, AB, Canada.
Abstract:
The BRCA1 BRCT domain binds pSer-x-x-Phe motifs in partner proteins to regulate the cellular response to DNA damage. Approximately 120 distinct missense variants have been identified in the BRCA1 BRCT through breast cancer screening, and several of these have been linked to an increased cancer risk. Here we probe the structures and peptide-binding activities of variants that affect the BRCA1 BRCT phosphopeptide-binding groove. The results obtained from the G1656D and T1700A variants illustrate the role of Ser1655 in pSer recognition. Mutations at Arg1699 (R1699W and R1699Q) significantly reduce peptide binding through loss of contacts to the main chain of the Phe(+3) residue and, in the case of R1699W, to a destabilization of the BRCT fold. The R1835P and E1836K variants do not dramatically reduce peptide binding, in spite of the fact that these mutations significantly alter the structure of the walls of the Phe(+3) pocket.
Insights
Structural and binding studies of BRCA1 BRCT variants reveal how mutations impact DNA damage response and cancer risk. Understanding these changes is crucial for breast cancer screening and genetic counseling.
Area of Science:
- Biochemistry
- Molecular Biology
- Genetics
Background:
- The BRCA1 BRCT domain is critical for DNA damage response by binding pSer-x-x-Phe motifs.
- Numerous missense variants in the BRCA1 BRCT domain are identified during breast cancer screening, with some linked to elevated cancer risk.
Purpose of the Study:
- To investigate the structural and peptide-binding characteristics of BRCA1 BRCT variants affecting the phosphopeptide-binding groove.
- To elucidate the functional impact of specific mutations on protein interactions and DNA repair.
Main Methods:
- X-ray crystallography to determine variant structures.
- Peptide-binding assays to assess interaction affinities.
- Analysis of variant effects on the BRCT phosphopeptide-binding groove.
Main Results:
- G1656D and T1700A variants highlight the importance of Ser1655 in phosphoserine recognition.
- Arg1699 mutations (R1699W, R1699Q) substantially decrease peptide binding due to altered interactions with the Phe(+3) residue and, for R1699W, BRCT fold destabilization.
- R1835P and E1836K variants show altered Phe(+3) pocket structure but retain significant peptide binding.
Conclusions:
- Specific mutations in the BRCA1 BRCT domain can disrupt critical protein-protein interactions involved in DNA damage repair.
- Understanding variant effects provides insights into the molecular mechanisms underlying BRCA1-associated breast cancer risk.
- These findings can inform genetic variant interpretation and risk assessment in clinical settings.
More Related Videos
Related Concept Videos
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Phosphorylation
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
Signal Sequences and Sorting Receptors
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...

